CTXR vs TER · $13.4M cap vs P/E 76, rev $2.82B
Citius Pharmaceuticals Inc (CTXR) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
CTXR does not have a complete income-statement cache yet.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
CTXR currently screens at market cap $13.4M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the CTXR and TER stock pages for the full models.
Not investment advice.